Niagen Bioscience (NAGE) Operating Expenses (2010 - 2026)
Niagen Bioscience (NAGE) posted quarterly Operating Expenses of $18.4 million for Q1 2026, up 26.38% year-over-year from $14.6 million in Q1 2025, and up 4.44% quarter-over-quarter from $17.6 million in Q4 2025.
Niagen Bioscience (NAGE) Operating Expenses (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported Operating Expenses for 17 consecutive years, with $18.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 26.38% year-over-year to $18.4 million; the TTM figure through Mar 2026 stood at $70.8 million (up 30.46% YoY), while the FY2025 annual figure was $66.9 million, up 24.23% from the prior year.
- Operating Expenses improved to $18.4 million in Q1 2026 per NAGE's latest filing, from $17.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $18.4 million in Q1 2026 and bottomed at $11.1 million in Q4 2024.
- Historically, Operating Expenses has averaged $15.1 million across 5 years, with a median of $14.6 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses sank 31.65% — and 2025, when it soared 58.92%.
- Niagen Bioscience's Operating Expenses stood at $13.5 million in 2022, then fell by 2.64% to $13.1 million in 2023, then slipped by 15.41% to $11.1 million in 2024, then soared by 58.92% to $17.6 million in 2025, then advanced by 4.44% to $18.4 million in 2026.
- Business Quant data shows NAGE's Operating Expenses at $18.4 million in Q1 2026, $17.6 million in Q4 2025, and $17.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | 18.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.61 Mn |
| Mar 31, 2026 | 18.40 Mn |
| Dec 31, 2025 | 17.62 Mn |
| Sep 30, 2025 | 17.69 Mn |
| Jun 30, 2025 | 17.04 Mn |
| Mar 31, 2025 | 14.56 Mn |
| Dec 31, 2024 | 11.09 Mn |
| Sep 30, 2024 | 14.64 Mn |
| Jun 30, 2024 | 13.95 Mn |
| Mar 31, 2024 | 14.19 Mn |
| Dec 31, 2023 | 13.11 Mn |
| Sep 30, 2023 | 13.12 Mn |
| Jun 30, 2023 | 14.67 Mn |
| Mar 31, 2023 | 15.49 Mn |
| Dec 31, 2022 | 13.46 Mn |
| Sep 30, 2022 | 13.27 Mn |
| Jun 30, 2022 | 16.43 Mn |
| Mar 31, 2022 | 18.26 Mn |
| Dec 31, 2021 | 16.18 Mn |
| Sep 30, 2021 | 19.42 Mn |